NCT02576366View on ClinicalTrials.gov

Phenotypic Drug Probes as Predictors of Drug-drug Interactions With Tacrolimus

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

May 31, 2017

Study Completion Date

December 31, 2017

Conditions
Drug InteractionsKidney Transplantation
Interventions
DRUG

Voriconazole

DRUG

Rifampin

Trial Locations (1)

3000

University Hospitals Leuven, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT02576366 - Phenotypic Drug Probes as Predictors of Drug-drug Interactions With Tacrolimus | Biotech Hunter | Biotech Hunter